RecruitingNCT06289621
Brief transdiagnostic therapy for anxiety and PTSD in South African primary care
About this title
Brief Transdiagnostic Treatment for Anxiety Disorders and Post-traumatic Stress Disorder (PTSD) in South Africa
Read the official source — NCT06289621Behavioural studyAges 18–65South Africa
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Cape TownSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 8, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural
- Locations
- South Africa
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06289621
- Official title
Show the full official title
Brief Transdiagnostic Treatment for Anxiety Disorders and PTSD in South Africa: A Hybrid-Effectiveness-Implementation Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Cape Town
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
